C

Cyclacel Pharmaceuticals

D

CYCC

USD

-0.02

(-1.9417%)

Market Closed

158.000

حجم التداول

-3.72

الربح لكل سهم

-

العائد الربحي

-0.065970

P/E

1,993,946.04

حجم السوق

اليوم

-1.9417%

1 اسبوع

-1.942%

1 شهر

-17.213%

6 اشهر

-57.563%

12 اشهر

-76.782%

بداية السنة

-62.313%

كل الوقت

0%

أصول ذات صلة

Title:
Cyclacel Pharmaceuticals

Sector:

Healthcare

Industry:

Biotechnology

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا